itsasurewin
Posted - 4 days ago
$RKDA $RLAY $RLFTF $RKLB $CERO
Aviptadil
Posted - 1 week ago
$RLFTF Getting caught up with a sick sociopath like Dr. Javitt, the optometrist, is just our luck. On to bigger and better.
Aviptadil
Posted - 1 week ago
$RLFTF Ever wonder if Fauci truly destroyed any chance of success for aviptadil? Ted Cruz wrote this letter and asked for results and it was deemed futile after being the last drug remaining in the platform clinical trial by the NIH. Given only to those who already too Remdesevir. It cost me everything but the science was there though i didn’t realize the game was rigged. I plan to do all I can to contact RFK and get this drug back.
Muzz1066
Posted - 1 week ago
$RLFTF tempting to add and average down again...
Aviptadil
Posted - 2 weeks ago
$RLFTF “Suppression of peptides…”
Aviptadil
Posted - 2 weeks ago
$RLFTF Ram has gotten such a raw deal. He never wanted to pursue aviptadil as a Covid cure but was forced to. There’s more to this RM than meets the eye. Renexxion’s main drug deals with GI motility which is now becoming one of the most common issues with people due to the rise of Ozempic. Let Ram work..
Aviptadil
Posted - 2 weeks ago
$RLFTF $NVDA
the_franz
Posted - 2 weeks ago
$RLFTF Relief is currently valued at CHF 100 million in this reverse merger, which corresponds to CHF 7.122 per share, or around USD 8.25. Well, I'll be back on the sidelines to see how things develop.
Aviptadil
Posted - 10/30/24
$RLFTF Physiomimic technology on full display. Groundbreaking..
txinvestordude
Posted - 10/28/24
$RLFTF This growth would be great if they hadn't reduced my 15,000 shares down to 38. This POS needs to go up to $250 for me to break even. That would be higher than the all time high. So I'm not getting my hopes up.
Aviptadil
Posted - 10/28/24
$RLFTF $7.50; 52 week high on to bigger and better.
Aviptadil
Posted - 10/28/24
$RLFTF Epidermolysis Bullosa is devastating! A solution is coming.. The simulation has chosen Relief Therapeutics and everyone that was wronged so badly. Justice will be served for those that are worthy.
Aviptadil
Posted - 10/28/24
$RLFTF Lingering in the distance. The best solution to fight ARDS and symptoms of Pulmonary sarcoidosis that there has ever been. Fauci has destroyed the drug but soon he will be gone and RFK JR will bring it back and then… Relief Therapeutics will be back, along with all of us. “Unwavering Faith!” - J. Winston
Pennywise77
Posted - 10/28/24
@Stockingisland haha,omg, that was a nightmare stock, I lost alot of money in $RLFTF that was first stock I ever bought during covid in 2020, learned alot of lessons tho and doing better now, how u been?
meowmeowmeowmeow
Posted - 10/28/24
$RLFTF presumably RLF-OD032 will be a far superior treatment for PKU then Kuvan. so... lfg.
larumba
Posted - 10/25/24
@DavidBG This is what happens when people speak the truth about NRXP , @JavittMD and DavidBG. If a shareholder requests an update on catalysts such as the pain data or Hope dividend they threaten and call you a short. The walls are closing in on fat boy and his pumps. ——
Fundamental_illness
Mar 29, 2024 2:12 PM
$NRXP No Donnie, no Jake, no Carlos, no Penny, no Bonkers... now those were the days
——
Pennywise77
Mar 30, 2024 8:26 PM
@Fundamental_illness hey bro, I'm still in the market, but had to get away from $nrxp $rlftf Dr Javitt started contacting me with threats of lawsuits because I was speaking the truth, I see he has a whole new group of Investers believing his BS, lol, hope all is well, happy easter!!
——-
All these characters that were silenced by Javitt & DavidBG in the past were correct. You won’t find a bigger fraud on this platform than DavidBG aka as JavittMD.
Thomas105
Posted - 10/25/24
$RLFTF Relief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional Patents
New Study Results Indicate Superior Absorption of RLF-OD032 in Fasted State Compared to KUVAN®, Potentially Enabling Flexible Dosing Options
GENEVA (OCT. 25, 2024)
LewisDaKat
Posted - 1 month ago
News out $RLFTF Relief Therapeutics Receives Notice of Allowance for European Patent Covering RLF-TD011 for Epidermolysis Bullosa Wound Treatment https://marketwirenews.com/news-releases/relief-therapeutics-receives-notice-of-allowance-for-7090256568131659.html $RLFTF
Muzz1066
Posted - 1 month ago
$RLFTF nice bit of news to keep the momentum going. Now we just need a partnership with big pharma to study Aviptadil and we'll be laughing!
Thomas105
Posted - 1 month ago
$RLFTF If the upcoming bioequivalence study is a success, approval is highly likely. As a reminder, the reference product KUVAN achieved sales of around $180 million in 2023.
"Relief plans to advance RLF-OD032 into a pivotal bioequivalence trial as part of the 505(b)(2) NDA submission process in the United States and pursuant to the development guidance previously provided by the FDA in a pre-IND meeting."
From website thefdagroup.com
"While some differences in formulation or administration might require additional clinical studies for 505(b)(2) applicants, these are typically less extensive than what’s required for original innovator drugs. In many cases, a bioequivalence study suffices to demonstrate the similarity between the two drugs, leading to FDA approval. In instances where additional clinical studies are needed, the requirements are generally less stringent.
Again, the pathway also presents an opportunity for market exclusivity ranging from 3 to 7 years."
Muzz1066
Posted - 1 month ago
$RLFTF big positive surprise on earnings, good incoming milestone payments and loads of cash on hand. Up big last month but a long ways to go $DRUG
Thomas105
Posted - 1 month ago
$RLFTF Larger buy order at 4.76
I think the price needs further stability between 5 - 5.50 francs, after which it should go further towards 7-8 francs.
Thomas105
Posted - 1 month ago
$RLFTF Seems to be promising market
VYJUVEK® for the treatment of Dystrophic Epidermolysis Bullosa (DEB)
The Company recorded $70.3 million in VYJUVEK net product revenue for the second quarter of 2024, an increase of 55.3% compared to the first quarter of 2024. Gross margin for the quarter was 91%.
Skyzdalimit4u82
Posted - 1 month ago
$RLFTF Had to get out of this with a loss but this recent rise def softens the blow, good luck to all of you, hopefully I sound early as I know many may be in deep.
